Overview
Factor assays measure the functional activity of a specific coagulation factor, usually expressed in IU/dL or % activity.
Clinical Importance
To identify specific factor deficiencies after abnormal screening assays
To monitor selected factor replacement therapies
Specimen Requirements
- Specimen: platelet-poor plasma prepared from whole blood
- Tube: light-blue top; 3.2% sodium citrate (0.109 mol/L)
- Anticoagulant ratio: 9:1 blood-to-citrate (CLSI H21); fill to the tube fill line
- Handling: invert gently; transport promptly; avoid traumatic draws and line heparin contamination
- Processing: centrifuge to platelet-poor plasma per institutional protocol before testing
- Stability: assay-specific (CLSI H21). aPTT is generally less stable than PT; do not exceed validated time/temperature limits for the ordered tests.
Analytical Method
One-stage assays: patient plasma is mixed with factor-deficient substrate plasma; correction of clotting time is proportional to factor activity.
Chromogenic assays use factor-specific enzymatic color generation and can reduce some interference patterns.
Instruments Used
Automated analyzers
- Sysmex CS / CN coagulation analyzers
- Werfen / Instrumentation Laboratory ACL TOP coagulation analyzers
- Siemens Healthineers BCS coagulation analyzers
- Stago STA Compact / STA R Max coagulation analyzers
Manual methods
- Manual tilt-tube clotting methods (selected reference/backup contexts)
Reference Values
Typical adult SI examples below follow widely published international hematology practice (e.g., Dacie and Lewis; Henry's). Always interpret against the method- and demographics-specific interval printed on the patient report (CLSI EP28-A3c). Neonatal, pediatric, pregnancy, and altitude intervals differ.
Many clotting factors are cited near 50 to 150 IU/dL (about 50 to 150% activity) in healthy adults. Assay-, age-, and ABO-related (factor VIII/vWF) variation applies; use local intervals.
Interpretation
Common Causes of Increased Results
- Elevated factor VIII can occur as an acute-phase response
Common Causes of Decreased Results
- Reduced activity indicates deficiency or inhibitor effect depending on assay design and mixing results
Clinical Significance
- Characterization of hemophilia and rare factor deficiencies
- Investigation of unexplained PT/aPTT prolongations
Factors Affecting Results
Pre-analytical
- Underfilled citrate tube (excess anticoagulant prolongs clotting times)
- Overfilled tube or clot in specimen
- Hematocrit >55% may require adjusted citrate volume (CLSI H21 guidance)
- Delayed processing or improper storage beyond assay stability
- Heparin contamination from line draws
Analytical
- Reagent lot / instrument calibration differences
- Lipemia, hemolysis, or icterus interfering with photo-optical endpoints
Post-analytical
- Applying another laboratory's reference interval
- Misreading INR therapeutic targets as untreated reference intervals
Advantages and Limitations
Advantages
- Specific pathway localization
- Guides targeted therapy
Limitations
- Inhibitors and lupus anticoagulant can confound one-stage assays
- Require specialized reagents and expertise
Clinical Pearls
If factor VIII looks low but the clinical story fits von Willebrand disease, measure vWF assays; they travel together in physiology.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Rodak BF, Carr JH. Rodak's Hematology: Clinical Principles and Applications. 6th ed. Elsevier; 2020.
- Hoffbrand AV, Moss PAH, Pettit JE. Essential Haematology. 8th ed. Wiley-Blackwell; 2019.
- McKenzie SB, Williams JL. Clinical Laboratory Hematology. 4th ed. Pearson; 2022.
- Bain BJ, Bates I, Laffan MA. Dacie and Lewis Practical Haematology. 12th ed. Elsevier; 2017.
- Kaushansky K, et al. Williams Hematology. 10th ed. McGraw-Hill; 2021.
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. Elsevier; 2018.
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline. CLSI document H21-A5. CLSI; 2017.
- Clinical and Laboratory Standards Institute. One-Stage Prothrombin Time (PT) Test and Partial Thromboplastin Time (PTT) Test; Approved Guideline. CLSI document H47-A2. CLSI; 2008.
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Standard. CLSI document EP28-A3c. CLSI; 2010.
- Clinical and Laboratory Standards Institute. Management of Critical- and Significant-Risk Results. CLSI guideline GP47-Ed1. CLSI; 2015.
Frequently Asked Questions
Common questions about using this Factor Assays laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Factor Assays laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Factor Assays. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Factor Assays specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Factor Assays. Confirm collection details against your laboratory protocol.
Where are Factor Assays reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Factor Assays results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Factor Assays?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Factor Assays?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Factor Assays?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Hematology topic.
What are the clinical pearls for Factor Assays?
See the Clinical Pearls section for concise laboratory practice notes associated with Factor Assays. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.